Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Therapy|December 30, 2025
Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2Daniel J Jackson, Arnaud Bourdin, Allison Blackorby, et al.
American Journal of Nephrology|February 5, 2023
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)Iain C Macdougall, Amy M Meadowcroft, Allison Blackorby, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2022
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trialsAjay K Singh, Finnian R McCausland, Brian L Claggett, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2021
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trialAjay K Singh, Allison Blackorby, Borut Cizman, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisAjay K Singh, Kevin Carroll, Vlado Perkovic, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Not Undergoing DialysisAjay K Singh, Kevin Carroll, John J V McMurray, et al.
JAMA Internal Medicine|April 4, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical TrialAjay K Singh, Borut Cizman, Kevin Carroll, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2021
The ASCEND-ND trial: study design and participant characteristicsVlado Perkovic, Allison Blackorby, Borut Cizman, et al.
Pageof 1